SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001492648-24-000001
Filing Date
2024-03-04
Accepted
2024-03-04 21:20:56
Documents
1
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3708
  Complete submission text file 0001492648-24-000001.txt   5316
Mailing Address C/O NEUROBO PHARMACEUTICALS, INC. 545 CONCORD AVENUE, SUITE 210 CAMBRIDGE MA 02138
Business Address
Woodworth Marshall H (Reporting) CIK: 0001492648 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37809 | Film No.: 24717992

Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Issuer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)